Jazz moves into Ireland with Azur buy
Thursday 19 January 2012 11.26
US company Jazz Pharmaceuticals has bought Irish firm Azur Pharma in a deal that creates a €1.5 billion specialty drug company headquartered in Dublin.
Now named Jazz Pharmaceuticals plc, it has about 430 employees – 20 in Dublin – with offices also in Philadelphia and Palo Alto.
One of the founders of Azur was former Elan executive Seamus Mulligan. Azur shareholders will own just over 20% of the new group, with Jazz shareholders owning the remainder of the combined firm.
RELATED AUDIO VIDEO
Azur Pharma sells ten drugs for the central nervous system and women’s health.
Jazz makes treatments for narcolepsy and obsessive compulsive disorder.
Bruce Cozadd, the group’s chief executive, told RTÉ radio it was too early to say how many new jobs would be created in Ireland, but he expected jobs growth to be “significant” in Dublin in the coming years.
feature” data-cycle-timeout=”0″ data-cycle-swipe=”true” data-cycle-next=”.highlights-nav.next” data-cycle-prev=”.highlights-nav.previous” data-cycle-disabled-class=”disabled” data-cycle-allow-wrap=”false” data-cycle-update-view=”1″ data-cycle-auto-height=”calc”>
Grafton Chief Executive Gavin Slark discusses the builders’ merchant and DIY retailer’s double-digit growth in percentage terms in revenue and profit in H1
Bord Gáís Energy Managing Director Dave Kirwan said the firm is reducing its residential electricity prices by 5% and its residential gas prices by 2%
Just Eat Managing Director for Ireland Amanda Roche Kelly discusses the brand’s presence at the upcoming Electric Picnic festival